CGRP Offers Relief From Migraine and Comorbid Depression
In patients with migraine and major depressive disorder, treatment with the anticalcitonin gene-related peptide (CGRP) fremanezumab reduced depression.
Source: medscape.com
Stay updated with breaking news from Elizabethw Loder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In patients with migraine and major depressive disorder, treatment with the anticalcitonin gene-related peptide (CGRP) fremanezumab reduced depression.
The system is in trouble. New incentives — money and more recognition — might fix it.